UPMC Hillman Cancer Center First in Western PA to Offer New Immunotherapy for Blood Cancer
January 18, 2018
January 18, 2018
PITTSBURGH, Pennsylvania, Jan. 18 -- The University of Pittsburgh Medical Center issued the following news release:
UPMC Hillman Cancer Center is now the only cancer center in western Pennsylvania, and among a select few cancer centers in the nation, certified to offer the latest immunotherapy for patients with non-Hodgkin's lymphoma.
YESCARTA(TM) (axicabtagene ciloleucel) CAR-T cell therapy, recently approved by the U.S. Food and Drug Administration for the treatm . . .
UPMC Hillman Cancer Center is now the only cancer center in western Pennsylvania, and among a select few cancer centers in the nation, certified to offer the latest immunotherapy for patients with non-Hodgkin's lymphoma.
YESCARTA(TM) (axicabtagene ciloleucel) CAR-T cell therapy, recently approved by the U.S. Food and Drug Administration for the treatm . . .